Abstract:Fetal hydrocephalus is a descriptive diagnosis of symptoms, which can result from numerous causes, including developmental anomalies, chromosomal disorders, genetic syndromes, and intrauterine infection (Tully and Dobyns 2014). Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS, OMIM# 307000), also named as X-linked hydrocephalus, was first described in the 1940s. Mutation of L1CAM gene is the most frequent cause of congenital hydrocephalus, accounting for 5–10% of males with isolated congenital hydrocephalus. Until now, more than 200 different L1CAM mutations have been reported in patients with HSAS (Vos and Hofstra 2010). Finckh et al. (2000) reported that the L1CAM mutation detection rate was 15.7% for patients without family history, 74.2% for those with at least two additional patients in the family. Conducting etiological analysis may improve prenatal diagnosis, prevention, management of possible complications, or recurrence risk of fetal hydrocephalus. This retrospective study included 13 male fetuses with isolated hydrocephalus who underwent invasive prenatal diagnosis at Nanjing Drum Tower Hospital from January 2013 to April 2015. Chromosomal disorders were excluded by karyotyping in all fetuses. Adverse pregnancy history of hydrocephalus was known in fetuses 7 and 9. No family history was known in all cases. The maternal and pregnancy characteristics of the study population are summarized in Table S1 (Supporting information). Of the seven fetuses who accepted further prenatal magnetic resonance imaging (MRI), additional brain abnormalities were detected in fetuses 1, 4, and 13 (Fig. S1). DNA sequencing revealed that fetus 4 carried a novel c.1078C>T transition in the exon 10 of L1CAM gene. This mutation altered a proline into serine on amino acid position 360 (p. Pro360 Ser). It was the first pregnancy of the healthy and nonconsanguineous couple. Further sequencing implied the mother was X-chromosome heterozygous for P360S mutation so that she could be a carrier. P360 residue was located in the extracellular domain which was highly conserved through evolution (Fig. 1). Previous studies on mutated L1 molecules provided evidence that missense changes in the extracellular domains had variable effects on homophilic and heterophilic binding of the molecule and might produce more severe neurological problems than mutations in only the cytoplasmic domain (De Angelis et al. 1999). Mutation Taster (http://www.mutationtaster.org), PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/), and SIFT (http://sift.jcvi.org/) were used to predict the impact of substitution at position 360 from P to S on the function of protein. The prediction scores for P360S mutation were evaluated by SIFT as 0 (damaging), by Mutation Taster as 0.999 (disease causing), and by PolyPhen-2 as 1.000 (probably damaging). Next, microdeletion/microduplication syndrome and intrauterine infection were excluded by chromosomal microarray analysis and intrauterine infection detection in this fetus. X-chromosome inactivation (XCI) status of the carrier mother was examined using androgen receptor methylation assay. The result revealed that the XCI ratio in maternal peripheral blood DNA was 71:29 (Fig. S2). Although the XCI ratio in peripheral blood DNA could not represent the ratio in brain, the mild skewed XCI on the mutation-bearing X chromosome may be a reason for the mother's normal phenotype. All these results supported that P360S mutation in L1CAM gene was the genetic etiology of hydrocephalus in fetus 4. Except for hydrocephalus, adducted thumbs, intellectual disability, and lower limb spasticity are the other possible clinical characteristics for HSAS (Vos et al. 2010). Adle-Biassette et al. (2013) reviewed detailed neuropathological data from cases with deleterious L1CAM mutations. Of the 57 fetuses, 100% had hydrocephalus, 88% had adducted thumbs, 98% had pyramidal tract agenesis/hypoplasia, 90% had stenosis of the aqueduct of Sylvius, and 68% had agenesis/hypoplasia of the corpus callosum. However, some clinical parameters such as mental retardation or spastic paraplegia cannot be applied to fetuses, and therefore comprehensive sonographic evaluation and fetal brain MRI were important to determine whether other structural abnormalities are present. For fetus 4, no more clinical findings were available because a fetal autopsy was refused by the parents, while dysmorphic corpus callosum detected by prenatal MRI supported the diagnosis of HSAS in the clinical phenotypes. In this study, L1CAM mutation was detected in 1 of 13 fetuses with isolated hydrocephalus. Although the sample size is too small to evaluate the detection rate of L1CAM mutation, our results imply that L1CAM mutation screening should be considered to male fetus with isolated hydrocephalus. None. Table S1 Summary of maternal and pregnancy characteristics. Fig. S1 Prenatal brain magnetic resonance imaging additional findings of fetuses 1, 4, and 13. (A) Axial T2-weighted image shows cerebral cortex developmental delay in fetus 1 at 28 weeks. (B) Axial T2-weighted image shows corpus callosum agenesis in fetus 4 at 25 weeks. (C) Axial T2-weighted image shows the absence of septum pellucidum and corpus callosum in fetus 13 at 27 weeks. Fig. S2 X-chromosome inactivation (XCI) assay of the carrier mother in case 4. (A) Maternal peripheral blood DNA without digestion process. (B) Fetal DNA without digestion process. (C) Maternal peripheral blood DNA digested by the methylation sensitive restriction enzyme HpaII. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

A novel nonsense mutation in the L1CAM gene responsible for X‐linked congenital hydrocephalus

A Novel Silent Mutation In The L1cam Gene Causing Fetal Hydrocephalus Detected By Whole-Exome Sequencing

Prenatal Diagnosis of a Nonsense Mutation in the L1CAM Gene Resulting in Congenital Hydrocephalus: A Case Report and Literature Review

A novel splicing variation in L1CAM is responsible for recurrent fetal hydrocephalus

Novel Missense Mutation of L1CAM in a Fetus with Isolated Hydrocephalus

Functional study of a rare L1CAM gene c.1759G>C variant prove its pathogenicity

Targeted Sequencing Identifies A Novel Sh2d1a Pathogenic Variant In A Chinese Family: Carrier Screening And Prenatal Genetic Testing

A female case of L1 syndrome that may have developed due to skewed X inactivation

Case Report: Prenatal Diagnosis of Fetal Intracranial Hemorrhage Due to Compound Mutations in the JAM3 Gene

The genetic landscape of familial congenital hydrocephalus

A Case of Megalencephalic Leukoencephalopathy with Subcortical Cysts Type 1 Was Identified with a Novel Compound Heterozygous Alteration (c.135delc; C.423+2dupt) in China

GUCY2D Gene Loss-of-Function Mutations Responsible for Leber Congenital Amaurosis 1

Exome Sequencing Identifies NMNAT1 Mutations As a Cause of Leber Congenital Amaurosis

A Novel Missense Mutation in the FERM Domain Containing 7 (FRMD7) Gene Causing X-linked Idiopathic Congenital Nystagmus in a Chinese Family.

Identification of A Novel Missense Mutation of Mip in A Chinese Family with Congenital Cataracts by Target Region Capture Sequencing

Case report: Analysis of a gene variant and prenatal diagnosis in a family with megalencephalic leukoencephalopathy with subcortical cysts

Impaired neural differentiation and glymphatic CSF flow in the Ccdc39 rat model of neonatal hydrocephalus: genetic interaction with L1cam

The contribution of single-gene defects to congenital cardiac left-sided lesions in the prenatal setting.

A novel heterozygous variant of FOXJ1 in a Chinese female with primary ciliary dyskinesia and hydrocephalus: A case report and literature review

Identification And Functional Analysis Of A Novel Lhx1 Mutation Associated With Congenital Absence Of The Uterus And Vagina

Case report: A novel CASK mutation in a Chinese female child with microcephaly with pontine and cerebellar hypoplasia